Patents by Inventor Erik Lippa

Erik Lippa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN
    Publication number: 20220175881
    Abstract: Disclosed herein are methods for the treatment of a patient having an exudative age-related macular degeneration and other conditions of the retina by administering a binding protein comprising an ankyrin repeat domain, wherein the binding protein is first administered in 2 to 5 doses, with an interval of 25 to 35 days between each dose, and then is administered in additional doses with a longer interval between doses.
    Type: Application
    Filed: October 13, 2021
    Publication date: June 9, 2022
    Inventors: Thomas Hohman, Janet Cheetham, Scott Whitcup, Erik Lippa
  • METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN
    Publication number: 20210008158
    Abstract: Disclosed herein are methods for the treatment of a patient having an exudative age-related macular degeneration and other conditions of the retina by administering a binding protein comprising an ankyrin repeat domain, wherein the binding protein is first administered in 2 to 5 doses, with an interval of 25 to 35 days between each dose, and then is administered in additional doses with a longer interval between doses.
    Type: Application
    Filed: January 31, 2020
    Publication date: January 14, 2021
    Inventors: Thomas Hohman, Janet Cheetham, Scott Whitcup, Erik Lippa
  • METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN
    Publication number: 20170157207
    Abstract: Disclosed herein are methods for the treatment of a patient having an exudative age-related macular degeneration and other conditions of the retina by administering a binding protein comprising an ankyrin repeat domain, wherein the binding protein is first administered in 2 to 5 doses, with an interval of 25 to 35 days between each dose, and then is administered in additional doses with a longer interval between doses.
    Type: Application
    Filed: August 5, 2016
    Publication date: June 8, 2017
    Inventors: Thomas Hohman, Janet Cheetham, Scott Whitcup, Erik Lippa
  • METHOD OF TREATING CONDITIONS OF THE EYE WITH AN ANTI-VEGF DARPIN
    Publication number: 20150126458
    Abstract: Disclosed herein are methods for the treatment of a patient having an exudative age-related macular degeneration and other conditions of the retina by administering a binding protein comprising an ankyrin repeat domain, wherein the binding protein is first administered in 2 to 5 doses, with an interval of 25 to 35 days between each dose, and then is administered in additional doses with a longer interval between doses.
    Type: Application
    Filed: November 4, 2014
    Publication date: May 7, 2015
    Inventors: Thomas Hohman, Janet Cheetham, Scott Whitcup, Erik Lippa